Form 4: Morgan Stanley Executive Chairman James Gorman Sells 200,000 Shares
SEC Form 4 Filing
James Gorman, Executive Chairman of Morgan Stanley, sold 200,000 shares of common stock at an average price of $105.0615 on July 17, 2024.
Summary
- On July 17, 2024, James P. Gorman, the Executive Chairman of Morgan Stanley, sold 200,000 shares of Morgan Stanley common stock.
- The sale was executed at a weighted average price of $105.0615 per share.
- The price range for the individual transactions varied from $104.81 to $105.45.
- Following the transaction, Gorman directly owns 416,051.438 shares of Morgan Stanley common stock.
- Gorman also indirectly owns 150,000 shares through a Grantor Retained Annuity Trust and 2,008.032 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: Neutral sentiment. The document simply reports a stock sale by an executive, without indicating any specific positive or negative implications.
Negatives
- The sale of a significant number of shares by the Executive Chairman could be interpreted negatively by the market.
Risks
- Executive stock sales can sometimes signal a lack of confidence in the company's future performance, although this is not always the case.
Industry Context
Executive stock sales are a common occurrence, and their impact on the stock price can vary depending on the size of the sale, the executive's role, and the overall market sentiment.
Comparison to Industry Standards
- Executive stock sales are regularly monitored across the financial industry.
- Comparing Gorman's transactions to those of executives at firms like Goldman Sachs or JP Morgan Chase could provide context, but would require additional data on their filings.
- The size and frequency of such sales are often benchmarked against historical data and peer group activity to assess potential market impact.
Stakeholder Impact
- Shareholders may react to the news of the stock sale, potentially impacting the stock price.
- The sale could influence market perception of Morgan Stanley's financial health and future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/17/2024 | Date of the stock sale transaction. |
| 07/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.